Divarasib Versus Adagrasib or Sotorasib in Pretreated KRAS G12C+Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Gadgeel, S. [1 ]
Rahman, A. [2 ]
Osaghae, U. [3 ]
Fernando, T. M. [3 ]
Lin, M. T. [3 ]
Koli, K. [3 ]
Meyenberg, C. [4 ]
Mathisen, M. [3 ]
Skoulidis, F. [5 ]
机构：
[1] Henry Ford Hlth, Henry Ford Canc Inst, Detroit, MI USA
[2] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12D.07
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [41] Characteristics and Treatment Sequences of Patients with KRAS G12C, Other KRAS and KRAS-Wild-Type Advanced or Metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME Cohort
    Girard, Nicolas
    Perol, Maurice
    Debieuvre, Didier
    Lemonnier, Lydie
    Veillard, Charlotte
    Caillon, Megane
    Tzala, Lia
    Desamericq, Gaelle
    Audigier-Valette, Clarisse
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 342 - 342
  • [42] Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRAS G12C-Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report
    Stratton, Natalie
    Thompson, Jonathan
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (04):
  • [43] Real-world effectiveness and safety of sotorasib in patients with KRAS G12C mutated metastatic non-small cell lung cancer (NSCLC): Results of the IFCT-2102 Lung KG12Ci study
    Wislez, M.
    Mascaux, C.
    Cadranel, J.
    Thomas, Q.
    Ricordel, C.
    Swalduz, A.
    Pichon, E.
    Veillon, R.
    Gounant, V.
    Bussac, G. Rousseau
    Flandin, A-C. Madroszyk
    Daniel, C.
    Ravoire, M.
    Metivier, A-C.
    Fournel, P.
    Missy, P.
    Morin, F.
    Guisier, F.
    Westeel, V.
    ANNALS OF ONCOLOGY, 2023, 34
  • [44] Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC)
    Kim, Eejung
    Tong, Xinyuan
    Patel, Ayushi
    Liu, Shengwu
    Dilly, Julien
    Hover, Laura
    Mukhopadhyay, Suman
    Sherman, Fiona
    Christensen, James G.
    Olson, Peter
    Aguirre, Andrew
    Wong, Kwok
    Ji, Hongbin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Prevalence of KRAS p.G12C mutation in patients with metastatic non-small cell lung cancer in Argentina
    Mendoza Bertelli, Andrea
    Otero Pizarro, Maria Mercedes
    Fernandez, Maria Paz
    Dibarbora, Delfina
    Florencia Cantarella, Maria
    Damian Mahmoud, Yamil
    Girotti, Romina
    Guttlein, Leandro
    Chico, Isagani
    Brandalise, Patricia
    Dutra, Carolina
    Salanova, Ruben
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Biomarker subgroup analyses of the Phase III study CodeBreaK 200 comparing sotorasib to docetaxel in pretreated patients with KRAS G12C-mutated non-small cell lung cancer
    Schuler, M.
    de, langen A. J.
    Paz-Ares, L.
    Mountzios, G.
    Curioni-Fontecedro, A.
    Couraud, S.
    Jansenns, A.
    Rocco, D.
    Ohashi, K.
    Vincent, M.
    Kang, J. -H.
    Schvartsman, G.
    Lindsay, C.
    O'Byrne, O.
    Dziadziuszko, R.
    Andersen, J. L.
    Hindoyan, A.
    Wilmanski, T.
    Wang, Y.
    Skoulidis, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 148 - 149
  • [47] Early-stage KRAS G12C-mutated non-small cell lung cancer (NSCLC) in Australia.
    Mitchell, Paul
    Dharmaraj, Devisri
    Knight, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] The MET Inhibitor Tepotinib Potentially Inhibits KRAS G12C and SHOC2 in KRAS G12C Non-Small Cell Lung Cancer (NSCLC)
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. Prasad
    Prasad, A.
    Jantus-Lewintre, E.
    Ito, M.
    Cardona, A. F.
    Arrieta, O.
    Cao, P.
    Cai, X.
    Xing, B.
    Pedraz-Valdunciel, C.
    Dantes, Z.
    Sullivan, I.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez-Cao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S112 - S112
  • [49] KRAS G12C vs. non-G12C non-small cell lung cancer (NSCLC): Insights from gene expression analysis
    Pinto, L. Masfarre
    Clave, S.
    Sanchez, I.
    Perera-Bel, J.
    Berenguer-Molins, P.
    Bodalo-Torruella, M.
    Navarro-Gorro, N.
    Miquel, C.
    Torres, E.
    Garcia, A. Taus
    Del Rey-Vergara, R.
    Paricio, B. Bellosillo
    Da Rocha, P. F. Simoes
    Aperribay, E. Arriola
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03)
  • [50] Comparative Efficacy of Adagrasib and Sotorasib in KRAS G12C-Mutant NSCLC: Insights from Pivotal Trials
    Peng, Tzu-Rong
    Wu, Ta-Wei
    Yi, Tai-Yung
    Wu, An-Jan
    CANCERS, 2024, 16 (21)
12345